KR20240125633A - 산화질소-방출 비강 조성물 및 이의 사용 방법 - Google Patents
산화질소-방출 비강 조성물 및 이의 사용 방법 Download PDFInfo
- Publication number
- KR20240125633A KR20240125633A KR1020247024094A KR20247024094A KR20240125633A KR 20240125633 A KR20240125633 A KR 20240125633A KR 1020247024094 A KR1020247024094 A KR 1020247024094A KR 20247024094 A KR20247024094 A KR 20247024094A KR 20240125633 A KR20240125633 A KR 20240125633A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- buffer
- optionally
- nitric oxide
- paragraphs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/04—Nitro compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290928P | 2021-12-17 | 2021-12-17 | |
| US63/290,928 | 2021-12-17 | ||
| PCT/US2022/081754 WO2023114971A1 (en) | 2021-12-17 | 2022-12-16 | Nitric oxide-releasing nasal compositions and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240125633A true KR20240125633A (ko) | 2024-08-19 |
Family
ID=86773604
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247024094A Pending KR20240125633A (ko) | 2021-12-17 | 2022-12-16 | 산화질소-방출 비강 조성물 및 이의 사용 방법 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049841A1 (https=) |
| EP (1) | EP4447946A4 (https=) |
| JP (1) | JP2024547022A (https=) |
| KR (1) | KR20240125633A (https=) |
| CN (1) | CN118742298A (https=) |
| AU (1) | AU2022409833A1 (https=) |
| CA (1) | CA3240044A1 (https=) |
| IL (1) | IL313526A (https=) |
| WO (1) | WO2023114971A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1871433B1 (en) * | 2005-03-24 | 2009-04-22 | NOLabs AB | Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor |
| EP1888510A4 (en) * | 2005-05-27 | 2013-01-16 | Univ North Carolina | NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS |
| WO2010044875A2 (en) * | 2008-10-16 | 2010-04-22 | Novan, Inc. | Nitric oxide releasing particles for oral care applications |
| AU2015229626B2 (en) * | 2014-03-14 | 2021-05-20 | Sanotize Research And Development Corp. | Treating diseases using nitric oxide releasing solutions |
| WO2016160089A1 (en) * | 2015-03-27 | 2016-10-06 | Novan, Inc. | Topical antiviral compositions, delivery systems, and methods of using the same |
| EP3177262A4 (en) * | 2014-08-08 | 2018-04-18 | Novan Inc. | Topical emulsions |
| US11166980B2 (en) * | 2016-04-13 | 2021-11-09 | Novan, Inc. | Compositions, systems, kits, and methods for treating an infection |
| GB2599818B (en) * | 2019-06-04 | 2024-01-31 | Thirty Respiratory Ltd | Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract |
| CN112791096A (zh) * | 2020-12-31 | 2021-05-14 | 南京诺令生物科技有限公司 | 一种可自提供一氧化氮的洗鼻盐及其应用 |
-
2022
- 2022-12-16 US US18/719,012 patent/US20250049841A1/en active Pending
- 2022-12-16 AU AU2022409833A patent/AU2022409833A1/en active Pending
- 2022-12-16 CN CN202280092092.3A patent/CN118742298A/zh active Pending
- 2022-12-16 IL IL313526A patent/IL313526A/en unknown
- 2022-12-16 KR KR1020247024094A patent/KR20240125633A/ko active Pending
- 2022-12-16 EP EP22908737.4A patent/EP4447946A4/en active Pending
- 2022-12-16 WO PCT/US2022/081754 patent/WO2023114971A1/en not_active Ceased
- 2022-12-16 JP JP2024536373A patent/JP2024547022A/ja active Pending
- 2022-12-16 CA CA3240044A patent/CA3240044A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4447946A4 (en) | 2026-01-07 |
| IL313526A (en) | 2024-08-01 |
| AU2022409833A1 (en) | 2024-06-20 |
| WO2023114971A1 (en) | 2023-06-22 |
| US20250049841A1 (en) | 2025-02-13 |
| CA3240044A1 (en) | 2023-06-22 |
| EP4447946A1 (en) | 2024-10-23 |
| CN118742298A (zh) | 2024-10-01 |
| JP2024547022A (ja) | 2024-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11826382B2 (en) | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses | |
| AU2017273508A1 (en) | Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof | |
| US20220110968A1 (en) | Compositions and methods to disinfect, treat and prevent microbial infections | |
| KR20240125633A (ko) | 산화질소-방출 비강 조성물 및 이의 사용 방법 | |
| US11642372B2 (en) | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses | |
| TW201350138A (zh) | 妥布黴素調配物 | |
| JP2024128022A (ja) | 微生物感染を消毒、処置および予防するための組成物および方法 | |
| US12042514B2 (en) | Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses | |
| CN113244262A (zh) | 一种用于预防及治疗呼吸道感染性疾病的吸入粉雾制剂 | |
| WO2021191904A1 (en) | Methods for preventing and treating viral infection | |
| WO2023021329A1 (en) | Compositions and methods to disinfect, treat and prevent microbial infections | |
| AU2022410715B2 (en) | Pharmaceutical combination for the treatment of the respiratory infection caused by sars-cov-2 | |
| CN102369012B (zh) | 氧化氘用于治疗病毒性呼吸道疾病的用途 | |
| US11986516B2 (en) | Compositions and methods for treatment of SARS-COV-2 | |
| RU2860904C1 (ru) | Способ ингибирования вируса SARS-CoV-2 в тканях легких, являющихся органом-мишенью, путем ингаляции водного раствора диэтилдитиокарбамата натрия в аэрозольной форме | |
| US20230226136A1 (en) | A synergistic formulation for management of respiratory pathogens including coronaviruses | |
| US20240091253A1 (en) | THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES | |
| EP4380549A1 (en) | Peptidase formulation for treatment of microbial infections in the upper respiratory tract | |
| US20240000878A1 (en) | Methods for treatment and/or prevention of viral infections | |
| EP4580598A1 (en) | Pharmaceutical dry powder composition and methods for treating respiratory tract infections | |
| JP2024547022A5 (https=) | ||
| CN113244263A (zh) | 一种用于预防及治疗呼吸道感染性疾病的雾化吸入制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |